Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/46302
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAskari, I. V.-
dc.contributor.authorOsipova, O. A.-
dc.date.accessioned2022-04-22T16:31:39Z-
dc.date.available2022-04-22T16:31:39Z-
dc.date.issued2019-
dc.identifier.citationAskari, I.V. Influence of beta-blockers on mechanical dyssynchrony and cardiac remodeling in patients with ischemic chronic heart failure in the setting of revascularization / I.V. Askari, O.A. Osipova // Research Results in Pharmacology. - 2019. - Vol. 5, № 1.- P. 1-13. - Doi: 10.3897/rrpharmacology.5.34073. - Refer.: p. 11-13.ru
dc.identifier.urihttp://dspace.bsu.edu.ru/handle/123456789/46302-
dc.description.abstractDiastolic dysfunction (DD) and cardiac dyssynchrony (DS) are involved in the progression of chronic heart failure (CHF). A comparative analysis was conducted of the effect of a 6-month course of nebivolol and bisoprolol on DD, DS and metalloproteinase-9 (MMP-9) level in patients with ischemic chronic heart failure with preserved ejection fraction (HFpEF) and with midrange ejection fraction (HFmrEF), as well as in patients with comorbid type 2 diabetes mellitus (T2DM) in the setting of coronary artery bypass grafting (CABG) after 6 months of therapyru
dc.language.isoenru
dc.subjectmedicineru
dc.subjectpharmacologyru
dc.subjectchronic heart failureru
dc.subjectcoronary heart diseaseru
dc.subjectdyssynchronyru
dc.subjectdiastolic functionru
dc.subjectcoronary artery bypass graftingru
dc.subjectmetalloproteinase-9ru
dc.subjectnebivololru
dc.subjectbisoprololru
dc.titleInfluence of beta-blockers on mechanical dyssynchrony and cardiac remodeling in patients with ischemic chronic heart failure in the setting of revascularizationru
dc.typeArticleru
Appears in Collections:Vol. 5, № 1

Files in This Item:
File Description SizeFormat 
Askari_Influence.pdf2.83 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.